Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial - Erwann P. Loret; Albert Darque; Elvenn A. Loret; Corinne Nicolino-Brunet; Sophie Morange; Elisabeth Castagnier; Josiane Casanova; Christine Caloustian; Charléric Bornet; Julie Coussirou; Jihen Bousseta; Bertrand Dussol; et al. (Elsevier, 2016)